Nuclear factor Erythroid 2-related factor (Nrf2): A potential therapeutic target for oral cancer - Molecular insights

Nuclear factor Erythroid 2-related factor (Nrf2): A potential therapeutic target for oral cancer - Molecular insights

Saved in:

Bibliographic Details
Main Authors:	Kaviyarasi Renu, Vishnu Priya Veeraraghavan, Abilash Valsala Gopalakrishnan
Format:	Article
Language:	English
Published:	Elsevier 2024-06-01
Series:	Oral Oncology Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2772906024001766
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Rutin-Activated Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2) Attenuates Corneal and Heart Damage in Mice
by: Promise M. Emeka, et al.
Published: (2024-11-01)

Nuclear Factor Erythroid 2-Related Factor 2 Intervenes the Release of Neutrophil Extracellular Traps during Lipopolysaccharide-Induced Acute Lung Injury in Mice
by: Junying Lu, et al.
Published: (2024-01-01)

Magnetic graphene oxide increases the biocompatibility and nuclear factor erythroid 2-related factor 2 antioxidant of human cumulus cells: A lab-trial study
by: Fahimeh Kabiri, et al.
Published: (2024-11-01)

Nanoengineered chemotherapy - A novel therapeutic strategy in oral cancer
by: Gayathri Rengasamy, et al.
Published: (2024-06-01)

Emerging therapeutic targets in oral squamous cell carcinoma: Insights from genetic alterations
by: Santosh R. Patil, et al.
Published: (2024-06-01)

Lipin-1: Is a promising therapeutic candidate for head and neck cancer
by: Kaviyarasi Renu
Published: (2024-06-01)

Disruption of erythroid nuclear opening and histone release in myelodysplastic syndromes
by: Baobing Zhao, et al.
Published: (2019-03-01)

Daphnetin Protects Schwann Cells Against High-Glucose-Induced Oxidative Injury by Modulating the Nuclear Factor Erythroid 2-Related Factor 2/Glutamate–Cysteine Ligase Catalytic Subunit Signaling Pathway
by: Chih-Yuan Ko, et al.
Published: (2024-10-01)

Bispecific T-cell engagers in oral cancer immunotherapy
by: Veeraraghavan Vishnu Priya
Published: (2024-06-01)

Can vimentin be an emerging early detection molecular biomarker in oral squamous cell carcinoma?
by: Kalaiselvi Krishnamoorthy, et al.
Published: (2024-06-01)

Immunonutrition: A paradigm shift in oral cancer management
by: Vishnu Priya Veeraraghavan
Published: (2024-06-01)

CDK5RAP2: A potential prognostication biomarker for oral squamous cell carcinoma?
by: Benson Paul, et al.
Published: (2024-06-01)

Promoting oral cancer awareness in LGBTQ+ communities - Diversity in oral health
by: Gayathri Rengasamy, et al.
Published: (2024-09-01)

Nuclear factor erythroid 2-related factor 1 regulates the expression of proteasomal genes in ketotic cows and protects mammary cells against free fatty acid–induced endoplasmic reticulum stress
by: Taiyu Shen, et al.
Published: (2025-01-01)

Alpha-Hemoglobin-Stabilizing Protein: An Erythroid Molecular Chaperone
by: Maria Emília Favero, et al.
Published: (2011-01-01)

Exploring the potential of bioluminescence in oral cancer
by: Vishnu Priya Veeraraghavan, et al.
Published: (2024-03-01)

Exosome mediated tailored therapy for oral cancer
by: Gayathri Rengasamy, et al.
Published: (2024-06-01)

CD44: From diagnosis to therapy in the journey of oral cancer
by: Selvaraj Jayaraman, et al.
Published: (2024-06-01)

Correction: Kannampuzha et al. A Systematic Role of Metabolomics, Metabolic Pathways, and Chemical Metabolism in Lung Cancer. <i>Vaccines</i> 2023, <i>11</i>, 381
by: Sandra Kannampuzha, et al.
Published: (2024-12-01)

NGS revolutionizing oral cancer: From genetic profiling to personalized therapy
by: Gayathri Rengasamy, et al.
Published: (2024-06-01)

Insights of nano drug delivery for cancer immunotherapy: Targeting tumor-associated macrophages in oral squamous cell carcinoma
by: Kalaiselvi Krishnamoorthy, et al.
Published: (2024-06-01)

Environmental pollution and its link to heightened oral cancer risk: A rapidly growing public health issue
by: Vishnu Priya Veeraraghavan, et al.
Published: (2024-06-01)

Effect of platelet-activating factor on the growth of human erythroid and myeloid CD34+ progenitors
by: F. Dupuis, et al.
Published: (1998-01-01)

Electroacupuncture attenuates ferroptosis by promoting Nrf2 nuclear translocation and activating Nrf2/SLC7A11/GPX4 pathway in ischemic stroke
by: Xi-chen Yang, et al.
Published: (2025-01-01)

The role of Nrf2 transcription factors in various physiological and pathological states
by: Deasyka Yastani, et al.
Published: (2024-07-01)

Advancements in targeted drug delivery: A promising approach in oral cancer treatment
by: Rajkumar Prabhakaran, et al.
Published: (2024-06-01)

Exploring the Nanopore principle based portable device in oral cancer can serve as potential diagnostic tool facilitating focused treatment
by: Arthisri Anandhi Sekar, et al.
Published: (2024-03-01)

Role of the transcription factor NRF2 in maintaining the integrity of the Blood-Brain Barrier
by: Eduardo Cazalla, et al.
Published: (2024-11-01)

Revolutionizing precision medicine in oral squamous cell carcinoma: Harnessing 3D in vitro models for translation
by: Nitesh Buldak, et al.
Published: (2024-09-01)

Targeting the Interplay Between Autophagy and the Nrf2 Pathway in Parkinson’s Disease with Potential Therapeutic Implications
by: Mengru Liu, et al.
Published: (2025-01-01)

Reorganisation of chromatin during erythroid differentiation
by: A. A. Khabarova, et al.
Published: (2019-02-01)

Cellular Reprogramming toward the Erythroid Lineage
by: Laura J. Norton, et al.
Published: (2011-01-01)

Deciphering genomic complexity: Understanding intratumor heterogeneity, clonal evolution, and therapeutic vulnerabilities in oral squamous cell carcinoma
by: Vishnu Priya Veeraraghavan, et al.
Published: (2024-06-01)

Hybrid computational models for integrating clinical and molecular OSCC biomarker data
by: Hema Shree Kasi Rajan, et al.
Published: (2024-06-01)

The significance of purity: Leukaemias involving the erythroid lineage
by: Vincenzo Liso, et al.
Published: (2020-10-01)

Pure erythroid leukemia in advanced breast cancer
by: Pasquale Niscola
Published: (2014-08-01)

PLK1 inhibition impairs erythroid differentiation
by: Peijun Jia, et al.
Published: (2024-12-01)

Uptake of Non-Transferrin Iron by Erythroid Cells
by: Eugenia Prus, et al.
Published: (2011-01-01)

Thyroid Hormone-Induced Cytosol-to-Nuclear Translocation of Rat Liver Nrf2 Is Dependent on Kupffer Cell Functioning
by: Luis A. Videla, et al.
Published: (2012-01-01)

Proteostasis Decline and Redox Imbalance in Age-Related Diseases: The Therapeutic Potential of NRF2
by: Brigitta Buttari, et al.
Published: (2025-01-01)